Mineishi Shin相关文献与解析，生知库 | 链接生命科学的每一步

Ssentongo, Paddy; Guare, Emma G; Song, Chen; Inoue, Yoshitaka; Sandhu, Manpreet; Annageldiyev, Charyguly; Sivik, Jeffrey; Rakszawski, Kevin; Naik, Seema; Minagawa, Kentaro; Mineishi, Shin; Paules, Catharine I

炎症/感染

多发性骨髓瘤

骨髓瘤

发表日期：2026

文献求助收藏

C-754-01. Burn Injury Drives Biphasic Macrophage Immune Reprogramming Through Locus-Specific Epigenetic Remodeling

C-754-01. 烧伤通过位点特异性表观遗传重塑驱动巨噬细胞双相免疫重编程

期刊:Leukemia & Lymphoma

影响因子:2.2

doi:10.3109/10428194.2014.974041

Innis-Shelton, Racquel D; Davis, Randall S; Lamb, Lawrence; Mineishi, Shin; Penatzer, Julia A; Chandran, Ramya; Thakkar, Rajan K; Kim, Hans; Maile, Robert; Higgs, Aidan; Gauthier, Marie; Hernandez, Denise A; Brant, Jason; Bacher, Rhonda; Wallet, Shannon M; Efron, Philip; Kladde, Michael P

Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AML

异基因造血干细胞移植的发展历程：主要关注急性髓系白血病

期刊:Cells

影响因子:5.2

doi:10.3390/cells14080572

Inoue, Yoshitaka; Cioccio, Joseph; Mineishi, Shin; Minagawa, Kentaro

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity

经基因工程改造的人类树突状细胞诱导产生的细胞毒性淋巴细胞具有强大的抗白血病活性。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-025-03971-y

Zhao, Chenchen; Jia, Bei; Jiang, Yixing; Shike, Hiroko; Annageldiyev, Charyguly; Cioccio, Joseph; Minagawa, Kentaro; Mineishi, Shin; Ehmann, WChristopher; Schell, Todd D; Cheng, Hua; Zheng, Hong

Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.

既往移植物抗宿主病史会影响异基因造血干细胞移植后复发性血液恶性肿瘤患者的供体淋巴细胞输注结果

期刊:British Journal of Haematology

影响因子:3.8

doi:10.1111/bjh.20215

Velasco Claudia Mae, Inoue Yoshitaka, Cioccio Joseph, Rakszawski Kevin, Songdej Natthapol, Nickolich Myles, Zheng Hong, Naik Seema, Ehmann Christopher, Mierski Joseph, Silar Brooke, Vajdic Caitlin, Greiner Robert, Brown Valerie, Mineishi Shin, Shike Hiroko, Minagawa Kentaro

Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis

中等剂量移植后环磷酰胺预防移植物抗宿主病的安全性和可行性

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-025-06657-8

Venugopal, Natasha; McGowan, Andrew; Inoue, Yoshitaka; Zheng, Hong; Cioccio, Joseph; Rakszawski, Kevin; Songdej, Natthapol; Nickolich, Myles; Naik, Seema; Ehmann, Christopher; Sivik, Jeffrey; Mierski, Joseph; Silar, Brooke; Vajdic, Caitlin; Shike, Hiroko; Mineishi, Shin; Minagawa, Kentaro

发表日期：2025

文献求助收藏

Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia

克拉屈滨预处理后行异基因移植，采用全身照射和移植后环磷酰胺治疗复发难治性白血病

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms25020957

Naik, Seema; Rakszawski, Kevin; Zheng, Hong; Claxton, David; Minagawa, Kentaro; Mineishi, Shin

白血病

发表日期：2024

文献求助收藏

Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02

患有再生障碍性贫血且携带疾病风险等位基因 HLA-B*40:02 的同胞造血干细胞移植后出现疾病复发

期刊:Blood Transfusion

影响因子:2.3

doi:10.2450/BloodTransfus.674

Khosla, Akshita; Inoue, Yoshitaka; Cioccio, Joseph; Rakszawski, Kevin; Songdej, Natthapol; Nickolich, Myles; Zheng, Hong; Naik, Seema; Ehmann, Christopher; Claxton, David; Rybka, Witold; Sivik, Jeffrey; Mierski, Joseph; Silar, Brooke; Vajdic, Caitlin; Hohl, Raymond; Shike, Hiroko; Mineishi, Shin; Minagawa, Kentaro

Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant

移植后环磷酰胺会改变免疫特征，导致同种异体造血干细胞移植后T细胞重建受损。

期刊:Journal of Hematology & Oncology

影响因子:40.4

doi:10.1186/s13045-022-01287-3

Zhao, Chenchen; Bartock, Matthew; Jia, Bei; Shah, Neal; Claxton, David F; Wirk, Baldeep; Rakszawski, Kevin L; Nickolich, Myles S; Naik, Seema G; Rybka, Witold B; Ehmann, W Christopher C; Hohl, Raymond J; Valentin, Jessica; Bernas-Peterson, Michelle; Gerber, Emily M; Zimmerman, Michele; Mierski, Joseph A; Mineishi, Shin; Zheng, Hong

A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia

一项针对不适合接受一线治疗的急性髓系白血病患者的阿维鲁单抗联合地西他滨的I期临床试验

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.26043

Zheng, Hong; Mineishi, Shin; Claxton, David; Zhu, Junjia; Zhao, Chenchen; Jia, Bei; Ehmann, W Christopher; Rybka, Witold B; Naik, Seema; Songdej, Natthapol; Drabick, Joseph J; Hohl, Raymond J

白血病

发表日期：2021

文献求助收藏

Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab

分析接受Teclistamab治疗的多发性骨髓瘤患者的真实世界感染风险

C-754-01. Burn Injury Drives Biphasic Macrophage Immune Reprogramming Through Locus-Specific Epigenetic Remodeling

C-754-01. 烧伤通过位点特异性表观遗传重塑驱动巨噬细胞双相免疫重编程

Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AML

异基因造血干细胞移植的发展历程：主要关注急性髓系白血病

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity

经基因工程改造的人类树突状细胞诱导产生的细胞毒性淋巴细胞具有强大的抗白血病活性。

Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.

既往移植物抗宿主病史会影响异基因造血干细胞移植后复发性血液恶性肿瘤患者的供体淋巴细胞输注结果

Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis

中等剂量移植后环磷酰胺预防移植物抗宿主病的安全性和可行性

Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia

克拉屈滨预处理后行异基因移植，采用全身照射和移植后环磷酰胺治疗复发难治性白血病

Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02

患有再生障碍性贫血且携带疾病风险等位基因 HLA-B*40:02 的同胞造血干细胞移植后出现疾病复发

Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant

移植后环磷酰胺会改变免疫特征，导致同种异体造血干细胞移植后T细胞重建受损。

A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia

一项针对不适合接受一线治疗的急性髓系白血病患者的阿维鲁单抗联合地西他滨的I期临床试验